Omega-3 PUFAs Can Reduce Smoking, Cut Tobacco Craving

This article originally appeared here.
Share this content:
Omega-3 PUFAs Can Reduce Smoking, Cut Tobacco Craving
Omega-3 PUFAs Can Reduce Smoking, Cut Tobacco Craving

(HealthDay News) -- Supplementation with omega-3 polyunsaturated fatty acids (PUFAs) can reduce daily smoking and tobacco craving, according to a study published in the Journal of Psychopharmacology.

Noting that low concentrations of omega-3 PUFAs can affect neurotransmission and may increase cigarette cravings, Sharon Rabinovitz, M.D., from the University of Haifa in Israel, examined the effect of PUFA supplementation on tobacco craving. Forty-eight regular cigarette smokers were administered 2,710 mg eicosapentaenoic acid/day and 2,040 mg docosahexaenoic acid/day for one month in a pilot study.

Rabinovitz found that PUFA supplementation for one month correlated with a significant reduction in reported daily smoking and in tobacco craving following cigarette cue exposure. In the month following treatment discontinuation, craving did not return to baseline values.

"This is the first study demonstrating that omega-3 PUFA supplementation reduces tobacco craving in regular smokers, compared to placebo treatment," Rabinovitz writes. "Thus, omega-3 PUFAs may be of benefit in managing tobacco consumption. Further studies are needed on larger samples to explore the possible therapeutic implications for heavy cigarette smokers."

Solgar Vitamin and Herb Company donated the omega-3 capsules used in the study.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »